Make a difference for Kyle

Kyle was diagnosed with stage 4 high risk Neuroblastoma in August 2020. He underwent 3 months intensive chemotherapy followed by high dose chemotherapy then 6 months of immunotherapy. He finished treatment at the end of October 2021 & rang the bell in December 2021 after his end of treatment scans. He still has inactive tumours in his chest & abdomen. Unfortunately in May 2023 he relapsed with an active tumour behind his Aorta. He had 6 rounds of BIT chemotherapy followed by a high risk surgery in December 2023. 3 weeks of Radiotherapy followed this once he was well enough. Treatment finished in March 2024. He then relapsed again in May 2025 with active disease in this skull. He started the Beacon 2 Trial which is a mix of chemotherapy & immunotherapy in June & has just finished his 10th cycle of 12. This treatment is due to finish at the end of February then he will hopefully start MIGB Therapy in March as long as he has a successful stem cell harvest in a couple of weeks.
His story, told by his mother